Pharmacogenomics : social, ethical, and clinical dimensions /
"Pharmacogenomics promises to revolutionize medicine by enabling the prevention, diagnosis, and treatment of diseases at the genome level. While a substantial amount of public and private research focuses on new pharmacogenomic applications, notably less attention has been directed to the ethic...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Hoboken, N.J. :
Wiley-Liss,
c2003.
|
| Subjects: | |
| Online Access: | Publisher description Book review (E-STREAMS) Table of contents |
| Summary: | "Pharmacogenomics promises to revolutionize medicine by enabling the prevention, diagnosis, and treatment of diseases at the genome level. While a substantial amount of public and private research focuses on new pharmacogenomic applications, notably less attention has been directed to the ethical, legal, and social implications of "individualized medicine. "Mark Rothstein's timely anthology reduced that scholarship deficit, presenting a multidisciplinary analysis of the scientific, clinical economic, ethical, social, and legal implications of pharmacogenomics." "Biotechnology and pharmaceutical researchers and regulators, health care professionals and students, and academics and policymakers will find Pharmacogenomic to be a valuable resource."--BOOK JACKET. |
|---|---|
| Physical Description: | xii, 368 p. : ill. ; 24 cm. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 0471227692 (cloth) |